The bcr/ablmRNA positive ration were 60.0% in the blood of 10 patients in CR during after therapy .

• 10例药物治疗缓解后的CML患者bcr/abl融合基因的检测阳性率为60.；0%25，与治疗前比较有显著性差异（P<0